©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 16, 2017; 5(6): 203-211
Published online Jun 16, 2017. doi: 10.12998/wjcc.v5.i6.203
Published online Jun 16, 2017. doi: 10.12998/wjcc.v5.i6.203
Clinical variants of pityriasis rosea
Francisco Urbina, Emilio Sudy, Dermatologists in Private Practice, Santiago de Chile 6760964, Chile
Anupam Das, Dermatology, KPC Medical College and Hospital, Kolkata, West Bengal 700032, India
Author contributions: All the authors have contributed to the preparation of the manuscript and collection of pictures.
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
Correspondence to: Francisco Urbina, MD, Dermatologist in Private Practice, Algeciras 583, Las Condes, Santiago de Chile 6760964, Chile. fcourbina@hotmail.com
Telephone: +56-22-2285427
Received: January 28, 2017
Peer-review started: February 9, 2017
First decision: March 7, 2017
Revised: March 21, 2017
Accepted: April 18, 2017
Article in press: April 19, 2017
Published online: June 16, 2017
Processing time: 137 Days and 11.7 Hours
Peer-review started: February 9, 2017
First decision: March 7, 2017
Revised: March 21, 2017
Accepted: April 18, 2017
Article in press: April 19, 2017
Published online: June 16, 2017
Processing time: 137 Days and 11.7 Hours
Core Tip
Core tip: Pityriasis rosea (PR) is a common, self-limited disease which in its typical form should not raise diagnostic doubts. Atypical forms represent 20% of cases, with diverse variants with respect to morphology and location of lesions, and evolution of the disease. Recognition of these forms may avoid unnecessary procedures. Drug ingestion may simulate PR in some cases.